News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,719 Results
Type
Article (14119)
Company Profile (283)
Press Release (250317)
Section
Business (79521)
Career Advice (153)
Deals (13226)
Drug Delivery (35)
Drug Development (50406)
Employer Resources (31)
FDA (5708)
Job Trends (5147)
News (144393)
Policy (10033)
Tag
Academia (907)
Alliances (21619)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5710)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4582)
Biotechnology (232)
Breast cancer (131)
Cancer (1113)
Cardiovascular disease (88)
Career advice (133)
CAR-T (92)
Cell therapy (272)
Clinical research (40566)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1301)
Earnings (29223)
Events (47704)
Executive appointments (353)
FDA (6216)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1072)
Healthcare (6581)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7249)
Job creations (860)
Job search strategy (128)
Layoffs (196)
Legal (1384)
Lung cancer (164)
Manufacturing (104)
Medical device (2582)
Medtech (2583)
Mergers & acquisitions (6211)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2015)
Non-profit (856)
Northern California (1340)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25384)
Phase I (14315)
Phase II (18878)
Phase III (11926)
Pipeline (504)
Postmarket research (852)
Preclinical (5996)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1417)
Regulatory (8446)
Research institute (933)
Series A (82)
Southern California (1188)
Startups (1973)
United States (10540)
Vaccines (189)
Weight loss (96)
Date
Last 7 days (339)
Last 30 days (1443)
Last 365 days (20389)
2025 (2648)
2024 (20568)
2023 (22433)
2022 (26841)
2021 (27831)
2020 (23379)
2019 (16253)
2018 (11763)
2017 (13763)
2016 (11849)
2015 (14368)
2014 (10395)
2013 (7490)
2012 (7534)
2011 (7617)
2010 (7432)
Location
Africa (149)
Asia (17109)
Australia (2894)
California (3049)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36805)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (396)
Massachusetts (2386)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1340)
Ohio (98)
Pennsylvania (577)
South America (208)
Southern California (1188)
Texas (340)
Washington State (291)
264,719 Results for "prelude therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Prelude Therapeutics to Participate in Upcoming June 2024 Healthcare Conferences
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in two upcoming healthcare conferences in June.
June 3, 2024
·
1 min read
Press Releases
Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
November 27, 2024
·
1 min read
BioCapital
Prelude Therapeutics to Participate in Citizens JMP Life Sciences 2024 Conference
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 and 14.
May 9, 2024
·
1 min read
Press Releases
Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 7, 2024
·
13 min read
Business
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, reported its financial results for the first quarter ended March 31, 2024 and provided an update on recent clinical development pipeline and other corporate developments.
May 7, 2024
·
11 min read
Press Releases
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium
October 9, 2024
·
6 min read
Press Releases
Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
December 11, 2024
·
7 min read
BioCapital
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference - February 29, 2024
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in the Barclays Global Healthcare Conference in Miami, March 12-14, 2024.
February 29, 2024
·
1 min read
Press Releases
Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium
October 25, 2024
·
10 min read
BioCapital
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, reported its financial results for the fiscal year ended December 31, 2023, and outlined key objectives for 2024.
February 15, 2024
·
11 min read
1 of 26,472
Next
